Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib for severe alopecia areata (phase 3)
CTR20211281Phase 3Completed
- Sponsor
- Suzhou Zelgen Biopharmaceuticals
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of jaktinib in alopecia areata, sponsored by Suzhou Zelgen Biopharmaceuticals. Started Jun 2021; status: completed.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20211281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211281.